(Total Views: 292)
Posted On: 11/19/2020 4:40:54 PM
Post# of 44

$AFMD News Article - Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD's anti-PD-1 therapy KEYTRUDA (pembrolizumab) in Blood https://marketwirenews.com/news-releases/affi...55862.html


My Twitter: WhyteStocks